Your session is about to expire
← Back to Search
Procedure
Diagnostic Knee Needle Arthroscopy for Osteoarthritis
N/A
Recruiting
Led By Joseph P Zimmerman, MD
Research Sponsored by Albany Medical College
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
Study Summary
This trial is testing whether needle arthroscopy (NA) is an effective, safe, and cost effective tool to confirm the presence of unicompartmental osteoarthritis (OA) and thus guide patient management in the decision to perform unicompartmental knee arthroplasty (UKA) or total knee arthroplasty (TKA).
Who is the study for?
This trial is for men and women aged 18-89 who may need knee surgery due to osteoarthritis. Candidates should have unclear x-rays that don't clearly show if they need partial or total knee replacement, can understand English, and give informed consent. People with inflammatory arthritis, certain knee deformities or limited motion, and those under 18 or over 89 are excluded.Check my eligibility
What is being tested?
The study tests a small camera called NanoScope™ for diagnosing knee problems without needing general anesthesia. It's used to decide whether patients with uncertain diagnoses should get partial (UKA) or total (TKA) knee replacements by directly viewing the joint in-office.See study design
What are the potential side effects?
Potential side effects of using the NanoScope™ needle arthroscopy might include discomfort at the insertion site, bleeding, infection risk, and possible damage to surrounding structures within the knee due to its invasive nature.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Visualization of unicompartmental or tricompartmental osteoarthritis
Trial Design
1Treatment groups
Experimental Treatment
Group I: Unicompartmental OA or equivocal findings in XRExperimental Treatment1 Intervention
After obtaining informed consent, patients will undergo needle arthroscopy, performed in the operating room prior to undergoing arthroplasty
Find a Location
Who is running the clinical trial?
Arthrex, Inc.Industry Sponsor
44 Previous Clinical Trials
29,772 Total Patients Enrolled
Albany Medical CollegeLead Sponsor
91 Previous Clinical Trials
11,387 Total Patients Enrolled
Andrew D Posner, MDStudy DirectorAlbany Medical College
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
California
Missouri
How old are they?
65+
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
Recent research and studies
Share this study with friends
Copy Link
Messenger